•  
  •  
  •  
  •  

2026-08-10 13:52:10

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Quality Power Electrical Equipments Posts Strong Q1 FY27 Results; Consolidated Net Profit Rises to ₹505.51 Million
  • Oswal Pumps Reports Q1 FY27 Results; Total Income at ₹4,817 Million, PAT at ₹538 Million
  • Sumedha Fiscal Services Reports Q1 FY27 Results; Consolidated Net Profit Rises 13.5% YoY to ₹330.77 Lakhs
  • Sky Gold & Diamonds Reports Record Q1 FY27 Performance
  • Quality Power Electrical Equipments Delivers Strong Operational Performance, Announces 2.5% Interim Dividend and Major Expansion Milestones

Keywords Selected:  OphthalmicSolution

Stock Report

  • Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004%
  • FDC Ltd receives USFDA approval for ANDA Pilocarpine Hydrochloride Ophthalmic Solutions
  • Gland Pharma receives approval from USFDA for Latanoprostene Bunod Opthalmic Solution
  • Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%
  • Caplin Steriles Ltd receives USFDA final approval for ANDA Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
  • Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
  • Glenmark Pharmaceuticals Inc., USA launches Travoprost Ophthalmic Solution USP, 0.004%
  • Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% OTC
  • Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution
  • Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
  • Lupin receives approval from U.S. FDA for Travoprost Ophthalmic Solution USP
  • Caplin Steriles gets USFDA approval for Ofloxacin Ophthalmic Solution
  • Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
  • Lupin launches Bromfenac Ophthalmic Solution, 0.075% in the United States
  • Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in the United States
  • Lupin receives approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%
  • Lupin receives approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.09%
  • Alembic Pharmaceuticals announces USFDA Final Approval for Brimonidine Tartrate Ophthalmic Solution, 0.15%

Latest Post

  • Quality Power Electrical Equipments Posts Strong Q1 FY27 Results; Consolidated Net Profit Rises to ₹505.51 Million
  • Oswal Pumps Reports Q1 FY27 Results; Total Income at ₹4,817 Million, PAT at ₹538 Million
  • Sumedha Fiscal Services Reports Q1 FY27 Results; Consolidated Net Profit Rises 13.5% YoY to ₹330.77 Lakhs
  • Sky Gold & Diamonds Reports Record Q1 FY27 Performance
  • Quality Power Electrical Equipments Delivers Strong Operational Performance, Announces 2.5% Interim Dividend and Major Expansion Milestones


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025